Sohn Catherine A.'s Form 4 filing
Maze Therapeutics, Inc. (MAZE) · filed Jan 8, 2026
- Accession no.
- 0001555132-26-000006
- Filed
- Jan 8, 2026
- Trade date
- Jan 6-7, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $1.15M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sohn Catherine A.CIK 0001555132 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Common Stock | MOption exerciseAcquired | +2,493 | $10.42 | +$25,977.06 | 2,493 | Direct | |
| Jan 6, 2026 | Common Stock | SSaleDisposed | −2,493 | $38.62 | −$96,279.66 | 0 | Direct | |
| Jan 7, 2026 | Common Stock | MOption exerciseAcquired | +20,744 | $10.42 | +$216,152.48 | 20,744 | Direct | |
| Jan 7, 2026 | Common Stock | MOption exerciseAcquired | +2,895 | $10.42 | +$30,165.9 | 23,639 | Direct | |
| Jan 7, 2026 | Common Stock | MOption exerciseAcquired | +3,281 | $10.42 | +$34,188.02 | 26,920 | Direct | |
| Jan 7, 2026 | Common Stock | SSaleDisposed | −26,920 | $39.11 | −$1,052,841.2 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Common Stock | MOption exerciseDisposed | −2,493 | $0.00 | $0 | 3,211 | Direct | |
| Jan 7, 2026 | Common Stock | MOption exerciseDisposed | −20,744 | $0.00 | $0 | 0 | Direct | |
| Jan 7, 2026 | Common Stock | MOption exerciseDisposed | −2,895 | $0.00 | $0 | 316 | Direct | |
| Jan 7, 2026 | Common Stock | MOption exerciseDisposed | −3,281 | $0.00 | $0 | 5,805 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.